Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.

Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.

Item

http://www.wikidata.org/entity/Q37835820

Q37835820

about

Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants The current role of thiazolidinediones in diabetes management.The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets.Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity.Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options.Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database.Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52).Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52).Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats Optimized mixture of hops rho iso-alpha acids-rich extract and acacia proanthocyanidins-rich extract reduces insulin resistance in 3T3-L1 adipocytes and improves glucose and insulin control in db/db mice Population Pharmacokinetics and Exposure-Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes.Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin-induced diabetic nephropathy in rats by reducing the hyperglycemia-induced inflammatory response Standards of care for type 2 diabetes in China.Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes.Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes.Examining the safety of PPAR agonists - current trends and future prospects.The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.Managing comorbidities in patients with chronic heart failure: first, do no harm.Management of Noncardiac Comorbidities in Chronic Heart Failure.Heart failure with reduced ejection fraction.Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials.Drug vs class-specific black box warnings: does one bad drug spoil the bunch?[Recommendations for the treatment of heart failure : What's new?].Population pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with type 2 diabetes.Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products.Exploring heart failure events in contemporary cardiovascular outcomes trials in type 2 diabetes mellitus.Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions.

P2860

Q26852019-45BB8805-FD2D-433A-B119-7809381FB336 Q27012801-B11FC61F-21E8-40F8-AD91-CBC309629475 Q27022813-3AA8734A-BCAB-4AC2-ACFB-387E456012C8 Q28238585-E637EE2A-2873-46A2-90C6-3CBE71DF0A41 Q30250347-EBA8224C-69AE-469B-816F-5115B7C4C268 Q33600053-0929A1A9-6C88-4DA4-BD23-42787ADF316D Q33808884-9046E21A-D230-4E62-A807-243D63BE47CF Q33839167-A7F98AB8-5DF7-4CF1-BC59-15E176D1778E Q33961458-C997CAA2-01B9-4BE5-9D05-05A37A6B718E Q34563587-BA7D2ACC-06F8-4261-8AF4-DA0BA613C1C4 Q35790650-6EAADB04-CF02-4B0B-A118-11E99C6E1FA8 Q35976501-3C74928A-3153-4435-B7C8-4A7287D32C32 Q35976506-017944A9-02E7-4BD0-87A0-5700CEB4F45E Q36034337-3BE49B83-E2B1-4046-B467-86BC9EAA9105 Q36203979-61E5644D-54FD-41C1-848A-5CB0C3A66BBD Q36424615-DC30198F-5B09-4BE0-AB82-332CE0DAE612 Q37239278-0A44764C-4779-4825-B0DF-53B29E005B1D Q37281904-0AF06C50-DDA8-42E4-8B51-67589C3CEA94 Q37412792-86AC298F-5ECC-4487-B8A1-1AF81603BE95 Q37620904-81713DBD-ACB4-473B-A4F1-07228383E052 Q37736845-2AC83300-FFC6-497E-9233-0101F477BC1C Q38058381-E0E523D9-5A65-45D6-846E-305F2D2D9B2C Q38102596-9B4B9282-3A46-4A80-8D09-48D66E78F1DE Q38402807-3DB7BF90-3A91-4830-BEF8-804003D7ACBE Q38537053-EB016D36-8954-4685-9A1D-72138EDB819C Q40081533-0F4574C0-4FC6-4964-A3E6-916E2A232E32 Q42379243-CB2F7188-F8E9-4000-96DC-484AB8B46C80 Q42739202-EC3B1D35-B831-447A-BB08-E643FF5F86B8 Q44770065-7E4C69F4-1DCC-4E59-883F-4F56A6C7576D Q45231648-308BA05E-2181-4CB4-AA8A-5372E5AE96A6 Q45721093-3EADCE92-6909-40FD-97F6-F61078591A88 Q47214520-0A067B5F-7FF7-4C57-B1C0-9E92E7A82FA8 Q52673331-00CC8FE4-01AD-481D-8F7A-7E13F9681929

P2860

Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.

Item

http://www.wikidata.org/entity/Q37835820

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs